Role of protein kinases in mediating diabetes-induced augmented vasoconstriction to endothelin-1 in the renal arteries of STZ-diabetic rats

Cell Biochemistry and Function

Volumn 24, Issue 5, 2006, Pages 397-405

  Yousif, Mariam H M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Diabetes; Endothelin 1; Genistein; Nifedipine; Renal artery; STZ

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCIUM CHANNEL L TYPE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NIFEDIPINE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RHO KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RAT STRAIN; RECEPTOR AFFINITY; RENAL ARTERY; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

AMIDES; ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; ENZYME INHIBITORS; FEMALE; GENISTEIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NIFEDIPINE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RENAL ARTERY; SIGNAL TRANSDUCTION; STAUROSPORINE; VASOCONSTRICTION; VASODILATOR AGENTS;

ANIMALIA;

EID: 33748585216     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1253     Document Type: Article

References (19)

1. 2 of vasoconstriction induced by an α-agonist in mesenteric arterial bed from diabetic rats. Diabetologia 1998; 41: 1410-1418.
2. Itoh Y, Nakai A, Kakizawa H, et al. Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI(2) derivative. Horm Res 2001; 56: 165-171.
3. Misurski DA, Wu SQ, McNeill JR, Wilson TW, Gopalakrishnan V. Insulin-induced biphasic responses in rat mesenteric vascular bed: role of endothelin. Hypertension 2001; 37: 1298-1302.
4. Hargrove GM, Dufresne J, Whiteside C, Muruve DA, Wong NC. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney. Kidney Int 2000; 58: 1534-1545.
5. Arikawa E, Verma S, Dumont AS, McNeill JH. Chronic bosentan treatment improves renal artery vascular function in diabetes. J Hypertens 2001; 19: 803-812.
6. Minchenko AG, Stevens MJ, White L, et al. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J 2003; 17: 1514-1516.
7. Tammesild PJ, Hodgson WC, King RG. Increased sensitivity to endothelin-1 in isolated KH-perfused kidneys of streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 1992; 19: 261-265.
8. Callera GE, Bendhack LM. Mechanisms underlying the contractile response to endothelin-1 in the rat renal artery. Pharmacology 2003; 68: 131-139.
9. Abebe W, Harris KH, MacLeod KM. Enhanced contractile responses of arteries from diabetic rats to alpha1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol 1990; 16: 239-248.
10. Weber LP, Macleod KM. Influence of streptozotocin diabetes on the alpha-1 adrenoceptor and associated G proteins in rat arteries. J Pharmacol Exp Ther 1997; 283: 1469-1478.
11. Yousif MH, Benter IF, Akhtar S. Inhibition of Ras-GTPase improves diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed. Med Principles Pract 2004; 13: 57-62.
12. Yousif MH, Cherian A, Oriowo MA. Endothelium-dependent relaxation in isolated renal arteries of diabetic rabbits. Auton Autacoid Pharmacol 2002; 22: 73-82.
13. US National Institute of Health. Care and Use of Laboratory Animals. NIH publication no. 85-23 (revised), 1985.
14. Toma C, Jensen PE, Prieto D, Hughes A, Mulvany MJ, Aalkjaer C. Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries. Br J Pharmacol 1995; 114: 1266-1272.
15. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 1993; 190: 968-974.
16. Chiarelli F, Trotta D, Verrotti A, Mohn A. Kidney involvement and disease in patients with diabetes. Panminerva Med 2003; 45: 23-41.
17. Kikkawa R, Koya D, Haneda M. Progression of diabetic nephropathy. Am J Kidney Dis 2003; 41: S19-S21.
18. Chang S, Hypolite JA, Changolkar A, Wein AJ, Chacko S, DiSanto ME. Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta. Int J Impot Res 2003; 15: 53-62.
19. Buyukafsar K, Un I. Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice. Eur J Pharmacol 2003; 472: 235-238.